(Q47745538)

5 February 2018

title

NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload (English)

1 reference

5 February 2018

author name string

Jing Zong

1

1 reference

5 February 2018

Mohamed Salim

2

1 reference

5 February 2018

Heng Zhou

3

1 reference

5 February 2018

Zhou-yan Bian

4

1 reference

5 February 2018

Jia Dai

5

1 reference

5 February 2018

Yuan Yuan

6

1 reference

5 February 2018

Wei Deng

7

1 reference

5 February 2018

Jie-yu Zhang

8

1 reference

5 February 2018

Rui Zhang

9

1 reference

5 February 2018

Qing-qing Wu

10

1 reference

5 February 2018

Qi-zhu Tang

11

1 reference

5 February 2018

publication date

19 August 2013

1 reference

5 February 2018

published in

Laboratory Investigation

1 reference

5 February 2018

volume

93

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

page(s)

1128-1136

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2013.99

exact match

0 references

cites work

Left ventricular hypertrophy: pathogenesis, detection, and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

The epidemiology of heart failure: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Lifetime Risk for Developing Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Cdc42 is an antihypertrophic molecular switch in the mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Multifarious molecular signaling cascades of cardiac hypertrophy: can the muddy waters be cleared?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

NODs: intracellular proteins involved in inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Functional consequences of NOD2 (CARD15) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

CARD15 mutations in Blau syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

NOD2: a potential target for regulating liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Role of NOD2/CARD15 in coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Effects of heme oxygenase-1 upregulation on blood pressure and cardiac function in an animal model of hypertensive myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

3,3'-Diindolylmethane protects against cardiac hypertrophy via 5'-adenosine monophosphate-activated protein kinase-α2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

The transcription factor GATA-6 regulates pathological cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Regulation of cardiac hypertrophy by intracellular signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Molecular targets and regulators of cardiac hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Regulation and function of the RSK family of protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

TGFbeta signalling: a complex web in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.99

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LABINVEST.2013.99

1 reference

5 February 2018

PubMed ID

23958879

1 reference

5 February 2018